Pinnacle Financial Partners (Georgia)’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$77.8M Sell
309,302
-2,073
-0.7% -$446K 0.53% 35
2026
Q1
$67.7M Buy
311,375
+2,613
+0.8% +$580K 0.52% 36
2025
Q4
$70.6M Buy
+308,762
New +$70.3M 0.53% 32

Other funds holding ABBV

Pinnacle Financial Partners (Georgia)'s ABBV Position: Q2 2026 in Review

Pinnacle Financial Partners (Georgia) reduced its AbbVie (ABBV) stake by 0.67% in Q2 2026, selling an estimated $446K and leaving 309,302 shares worth $77.8M. The position accounts for 0.53% of the portfolio, ranked #35.

Pinnacle Financial Partners (Georgia) first reported a position in ABBV in Q4 2025 and has held it in 3 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Pinnacle Financial Partners (Georgia) held 309,302 shares of AbbVie worth $77.8M as of Q2 2026.
  • Pinnacle Financial Partners (Georgia) sold 2,073 AbbVie shares in Q2 2026, an estimated $446K.
  • AbbVie made up 0.53% of Pinnacle Financial Partners (Georgia)'s portfolio in Q2 2026, its #35 holding.
  • Pinnacle Financial Partners (Georgia) first reported a position in AbbVie in Q4 2025 and has held it in 3 quarters since.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Pinnacle Financial Partners (Georgia)'s 13F filing for Q2 2026, filed 14 Aug 2026.